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Ethics in scientific research and in the publishing of papers in biomedical journals
EDITORIAL
This discussion about ethical and bioethical issues in scientific 
research with human beings is very much in need. Most of it because 
of the 5th article of the Biosafety Law, on the use of embryonic stem 
cells for research purposes, such fact has stirred not only the scientific 
community, but also the entire society. 
The matter was finally settled by a decision from the Federal 
Supreme Court, by six votes against five, that there is no legal hindrance 
to such types of experiment. 
For this reason, it is important to retake the theme of Ethics in 
Research, especially research involving human beings. Society, to whom 
we ultimately owe explanations, expects and demands from scientists 
and researchers that they always have in mind the limits that may and 
should be imposed to their actions and experiments.
The development of sciences in general, especially that of 
biological sciences, in the last century has been so great that today it 
is believed we have in the world more scientists than the sum of all of 
those who have already lived and died.
Based on this astronomic figure only, it is not wrong to suppose 
that there is and there will be increasingly more knowledge and new 
technologies produced for mankind. 
On the other hand, it is more than obvious that everyday we 
have more research, especially in health-care, including people as sub-
jects. In other words: research that use humans as their object of study, 
even when these studies intent to discover new possibilities for cure or 
treatment of the most diverse disorders.
Scientific research with human beings and for human beings has 
become a reason of concern in the western world after the discovery 
and disclosure of the atrocities committed by the Nazis during the 2nd 
world war, including “scientific” experiments in humans. 
Even more frightening is to know that such experiments were 
carried out or counted on the participation of researchers from the Nazi 
party, but who were very prestigious in the scientific world of those days; 
and with the help of research supporting entities and other agencies 
which had been created to promote health care to the population.
It was only then, after acknowledging the so called “crimes 
against humanity”, in 1947, that the Nuremberg Code was created, esta-
blishing the first norms to regulate research with humans.
Among these rules, there is the need for a voluntary free consent 
from the subject; for prior studies being carried out in laboratories and 
with animals; for the analysis of risks and benefits that the investigation 
may bring about; for the individual’s discretion to leave the study at any 
point during the project and for a proven qualification of the researcher 
to carry it on, among other issues.
It was already clear in this first (and we could say, already late) 
regulatory code, one of the cornerstone principles of bioethics, that of 
the subject’s autonomy, or as we said before, the “object-means” of the 
research. 
Even then, abuse continued to happen. In 1996, in the paper 
Ethics and clinical research, published by the New England Journal of 
Medicine, Beecker stressed the numerous research projects with human 
experimentation which were being carried out without proper ethical 
austerity, and even then published in renowned journals among the 
scientific community.
In these terms, the 1964 Nuremberg Code revision, during the 
18th Assembly of the World Medical Association, became another im-
portant landmark in the history of research with human beings. The so 
called “Helsinki Statement” was unprecedented in presenting the need 
for an independent committee to review these protocols.
In the following decades, the Standards have been revised and 
updated, peaking with those aiming at medical research without thera-
peutic ends, established by the 1996 48th Assembly, in South Africa. 
In the same year, in Brazil, a multidisciplinary group created the 
196/96 Resolution at the National Health Council, regulating the Standards 
to be followed when carrying out research with human beings. Among 
other provisions, which included the periodic review of such standards, 
the resolution embodied not only the individual’s autonomy, but also 
other important principles of Bioethics, such as doing good and not harm, 
justice, as well as equality and the right to confidentiality and privacy. 
Moreover, it is worth remembering other important provisions 
of this resolution, such as the concept of risk, which included not only 
the physical aspects, but also psychological, moral, cultural and social 
issues. On the other hand, it makes clear that “every procedure (of any 
nature) which is not fully established in the literature shall be considered 
as research with human beings”.
Obviously, many important topics were present in this resolution, 
among others; there is the need for a free informed consent, respect for 
the participant’s vulnerability, the need to justify the use of placebos, 
demonstration of the preponderance of benefits, and one of the most 
relevant: the possibility for the “object-means” of the research to have 
access to the data obtained. 
In these regards, the World Health Organization (WHO), as of 
the XXI century, has spared no efforts to create a universal data base of 
open access with the ongoing clinical trials involving human beings.
It is within this context, the bounding of all scientific experiments 
with human beings by well defined ethical principles that the editors of 
scientific journals (ultimately the means through which these experiments 
are disclosed) started to get involved with the ethical principles of the 
research being published. 
The rationale is logical: Ethics is not restricted only to the research 
preparation and the rules for the “object-means” participation, humans. 
It is completed with its publication in a scientific journal, and the editor 
of such publications can not help but act ethically, even checking the 
procedures used by the researchers.
Thus, the International Committee of Medical Journals Editors 
(ICMJE), in a joint effort with the WHO, established that they would only 
accept papers with on going clinical trials which had been validated by 
the WHO and ICMJE, starting in September of 2005.
As far as clinical trials go, the ICMJE defines every prospective 
research project which subject human beings to intervention and com-
parative study groups of cause-effect between a medical intervention 
and its results concerning the individual’s health. (http://www.who.int/
ictrp/faq/en/index.html). 
“Medical intervention” is defined as any procedure that may alter 
the individual’s health, such as the use of drugs and medication, surgical 
procedures, behavioral therapies, use of equipment, and others.
The Brazilian Journal of Otorhinolaryngology could not refrain 
from participating in this process and acknowledges the importance and 
validity of these initiatives by the WHO and the ICMJE. 
For these reasons, since 2007, we can only accept for publica-
tion in our journal, clinical trial papers that received an ID number in 
one of the Clinical Trial Registers validated by the criteria established 
by the WHO and the ICMJE, which web site addresses are available in 
the ICMJE web site http://www.icmje.org/ in the link “Frequently Asked 
Questions”.
For the authors, at the end of the paper submission process, 
we have added a checklist covering many aspects associated with text 
general structure and format that must be complied with. We reinforce 
that the ID number from the Clinical Trial Register does not replace 
the need for research project approval by the Ethics Committee of the 
institution where the study was carried out. Therefore, it is necessary to 
include both numbers in the paper. The register number at the end of 
the summary and the Ethics Committee Approval Protocol Number in 
the Materials and Methods part of the paper.
This is one more way to show that the Brazilian Otorhinola-
ryngology and especially Brazilian scientists in general, are in favor of 
the scientific progress, but all within Ethical Standards and respecting 
human dignity.
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